ACROBiosystems upgrades HEK293 solution for R&D compliance

ACROBiosystems has upgraded its global license solution for HEK293 functional cell lines to expedite biopharmaceutical R&D. Customers have authorisation to use HEK293 functional cell lines for research, discovery, and assay development. The policy applies in all global markets except Greater China, enabling access to HEK293 cell line products for R&D purposes. Credit: Gorodenkoff / Shutterstock.com. ACROBiosystems has upgraded its global licence solution for HEK293 functional cell lines, aimed at streamlining compliance to expedite biopharmaceutical research and development (R&D). The upgrade focuses on providing a unified and accessible framework, eliminating redundant review steps and supporting drug discovery and development projects. LOA…

Source: Pharmaceutical Technology